Feeds:
Posts
Comments

Posts Tagged ‘cardiovascular-related mortality’

PROSTATE HORMONE THERAPY: Measures needed against bone fracture, diabetes, heart risks

Posted in AFTER EFFECTS, Bone cancer, Hormone therapy, PROSTATE CANCER, PROSTATE RESEARCH, Salvage therapy, Testosterone treatment, Treatment debate, tagged , , , , , , , , , , , , , , , , on June 16, 2009| Leave a Comment »

JUNE 16: URO TODAY: Preventive measures against adverse effects and careful assessment of a patient’s baseline health status should be considered when using androgen deprivation therapy, say researchers in Texas. They found ADT is associated with an increased risk of skeletal fracture, incident diabetes, and cardiovascular-related mortality, although the absolute risk of these events is low. READ MORE>

Read Full Post »

PROSTATE RISK: Androgen therapy risks bone fracture, diabetes, heart problems

Posted in New prostate drugs, PROSTATE CANCER, PROSTATE RESEARCH, Treatment debate, Treatment news, tagged , , , , , , , , , , on May 1, 2009| Leave a Comment »

MED-SCAPE TODAY: Androgen-deprivation therapy (ADT) is a common treatment for men with prostate cancer, but patients who undergo this therapy are at an increased risk for skeletal fracture, incident diabetes, and cardiovascular-related mortality. READ MORE>

Read Full Post »